169 related articles for article (PubMed ID: 14206918)
1. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA.
SHULLENBERGER CC
Cancer Chemother Rep; 1964 Aug; 40():49-50. PubMed ID: 14206918
[No Abstract] [Full Text] [Related]
2. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
KRAKOFF IH; SAVEL H; MURPHY ML
Cancer Chemother Rep; 1964 Aug; 40():53-5. PubMed ID: 14206920
[No Abstract] [Full Text] [Related]
3. [THERAPEUTIC EFFECTS AND COMPLICATIONS IN CYTOSTATIC AND CORTISONE THERAPY OF LEUKOSES].
BREITFELLNER G; NEUHOLD R
Pathol Microbiol (Basel); 1964; 27():777-81. PubMed ID: 14235047
[No Abstract] [Full Text] [Related]
4. PEDIATRIC CLINICAL TRIALS WITH HYDROXYUREA (NSC-32065).
FERNBACH DJ
Cancer Chemother Rep; 1964 Aug; 40():37-8. PubMed ID: 14206913
[No Abstract] [Full Text] [Related]
5. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CARCINOMA OF THE LUNG.
BICKERS JN
Cancer Chemother Rep; 1964 Aug; 40():45-6. PubMed ID: 14206916
[No Abstract] [Full Text] [Related]
6. THE TREATMENT OF LEUKAEMIA AND ALLIED DISORDERS.
INNES J
Br J Clin Pract; 1964 Nov; 18():681-7. PubMed ID: 14230850
[No Abstract] [Full Text] [Related]
7. CHEMOTHERAPY OF ACUTE LEUKEMIA.
FREI E
CA Cancer J Clin; 1964; 14():252-6. PubMed ID: 14216115
[No Abstract] [Full Text] [Related]
8. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CANCER OF THE BREAST.
SEARS ME
Cancer Chemother Rep; 1964 Aug; 40():43. PubMed ID: 14206915
[No Abstract] [Full Text] [Related]
9. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MISCELLANEOUS TUMORS.
BLOEDOW CE
Cancer Chemother Rep; 1964 Aug; 40():39-41. PubMed ID: 14206914
[No Abstract] [Full Text] [Related]
10. MORPHOLOGIC ABNORMALITIES OF BONE MARROW CELLS INDUCED BY CHEMOTHERAPEUTIC AGENTS DURING TREATMENT OF LEUKEMIA.
KUNDEL DW; NIES BA
Am J Clin Pathol; 1965 Aug; 44():146-54. PubMed ID: 14323486
[No Abstract] [Full Text] [Related]
11. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: MULTIPLE MYELOMA AND LYMPHOMA.
DAVIS P
Cancer Chemother Rep; 1964 Aug; 40():51-2. PubMed ID: 14206919
[No Abstract] [Full Text] [Related]
12. HYDROXYUREA (NSC-32065): RESULTS OF A PHASE I STUDY.
GRIFFITH KM
Cancer Chemother Rep; 1964 Aug; 40():33-6. PubMed ID: 14206912
[No Abstract] [Full Text] [Related]
13. ANTILEUKEMIC ACTIVITY OF HYDROXYUREA (NSC-32065) AND OTHER UREA DERIVATIVES.
GOLDIN A; VENDITTI JM; MEAD JA; GLYNN JP
Cancer Chemother Rep; 1964 Aug; 40():57-74. PubMed ID: 14206921
[No Abstract] [Full Text] [Related]
14. ERYTHEMA IN AREAS OF PREVIOUS IRRADIATION IN PATIENTS TREATED WITH HYDROXYUREA (NSC-32065).
SEARS ME
Cancer Chemother Rep; 1964 Aug; 40():31-2. PubMed ID: 14206911
[No Abstract] [Full Text] [Related]
15. TRIAL OF HYDROXYUREA (NSC-32065) IN CANCER IN CHILDREN.
ORIGENES ML; BEATTY EC; BRUBAKER C; HAMMOND D; HARTMANN JR; SHORE N; WILLIAMS KO
Cancer Chemother Rep; 1964 Apr; 37():41-6. PubMed ID: 14165884
[No Abstract] [Full Text] [Related]
16. ACUTE LEUKEMIA TREATED WITH DIVIDED DOSES OF METHOTREXATE.
HUGULEY CM; VOGLER WR; LEA JW; CORLEY CC; LOWREY ME
Arch Intern Med; 1965 Jan; 115():23-8. PubMed ID: 14222475
[No Abstract] [Full Text] [Related]
17. HYDROXYUREA (NSC-32065)--A PHASE I STUDY.
BOLTON BH; KAUNG DT; LAWTON RL; WOODS LA
Cancer Chemother Rep; 1964 Jul; 39():47-51. PubMed ID: 14201275
[No Abstract] [Full Text] [Related]
18. ACUTE LEUKAEMIA ASSOCIATED WITH PHENYLBUTAZONE TREATMENT.
WOODLIFF HJ; DOUGAN L
Br Med J; 1964 Mar; 1(5385):744-6. PubMed ID: 14102019
[No Abstract] [Full Text] [Related]
19. HYDROXYUREA ADMINISTERED INTERMITTENTLY.
LERNER HJ; BECKLOFF GL
JAMA; 1965 Jun; 192():1168-70. PubMed ID: 14301045
[No Abstract] [Full Text] [Related]
20. THE LEUKEMIAS.
PETRAKIS NL
Calif Med; 1964 Jul; 101(1):33-41. PubMed ID: 14179529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
